IDBS and Titian to Provide Complete Solution for Drug Discovery Market
News Oct 03, 2007
IDBS has announced a strategic partnership with Titian Software Ltd (London, UK).
Titian specializes in sample management and provides inventory management solutions to enable the supply of compounds, reagents and biological samples to vital scientific research processes. Titian has worked with a broad range of customers, including major global pharmaceutical and smaller screening organizations.
IDBS and Titian have entered into a strategic collaboration whereby they will provide a comprehensive, customer-focused solution for life science organizations. IDBS’ applications will interact with Titian’s Mosaic inventory management system to streamline customer workflow, increasing screening efficiency, throughput and data integrity.
“This agreement represents a great opportunity to tailor our products towards our customers’ needs. IDBS’ industry-leading data management capabilities will complement our expertise in inventory management, strengthening our value proposition to the life science industry,” commented Richard Fry, co-founder and Commercial Director of Titian.
Neil Kipling, founder and CEO of IDBS, commented: “Increasingly our customers have indicated a need for flexible inventory management. Our customers will benefit from the direct integration with ActivityBase, providing them with the best possible solution for managing their screening and discovery data.”
The ideal drug is one that only affects the exact cells and neurons it is designed to treat, without unwanted side effects. This concept is especially important when treating the delicate and complex human brain. Now, scientists have revealed a mechanism that could lead to this kind of long-sought specificity for treatments of strokes and seizures.READ MORE